Skip to content
April 18, 2024

Equity.Guru

Investment information for the new generation

Search

Bioavailability

Xphyto Therapeutics (XPHY.C) provided a market and product update on its Rotigotine transdermal (TDS) patch, originally developed by their German subsidiary, Vektor Pharma TF GmbH. If you’re interested in…
Cybin (CYBN.E) filed a new provisional patent application for its ongoing drug candidate programs today, according to a press release. The application includes compositions which the company anticipates will…
BioHarvest Sciences (BHSC.C) has officially begun direct-to-consumer sales of VINIA®, the Company’s flagship product, in the Unites States, via its VINIA® website.     “This major event is the…
Core One Labs (COOL.C) inked a letter of intent to pick up pharmaceuticals company, Akome Biotech today, according to a press release. Akome develops psychedelic-based drugs to treat rare…
Core One Labs (COOL.C) signed a letter of intent today with Ketamine Infusion Centers of Texas (KICT) today to determine if the company would be an adequate fit for…
PLUS Products (PLUS.C) partnered with Israeli-based CannRx Biosciences today to enhance and improve-upon the onset time for their gummies and other cannabis-infused products, according to a press release. CannRx…
Pure Extracts Technologies (PULL.C) set their milestone timetable for their study on both the formulation and manufacturing of psilocybin-based treatments today, according to a press release. The study’s focus…
Pure Extracts Technologies (PULL.C) signed an letter of intent (LOI) with mushroom-derived wellness products company, Nutraceutical Medicine Company, to help springboard Pure’s expansion into the functional mushroom sector and…
The Green Organic Dutchman Holdings (TGOD.T) expanded its licensing agreement with Colorado-based Stillwater Brands, and will start selling its Ripple suite of products in Canada, including Ripple Gummies and…
The United States Patent and Trademark Office granted Nextleaf Solutions (OILS.C) their patent for the acetylation of cannabinoids today. The patent describes a process to refine delta 9-tetrahydrocannabinol (or…